Global Immune Health Product Market Size, Share, Trends and Forecast 2022-2030

Immune health products are health products that can improve immunity and promote metabolism.
Industry Insights

The global Immune Health Product market size is projected to reach US$ 75190 million by 2028, from US$ 48780 million in 2021, at a CAGR of 6.3% during 2022-2028.

Global Immune Health Product key players include Amway, Suntory, GNC, INFINITUS, Herbalife Nutrition, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe and China, both have a share over 37 percent. In terms of product, Capsule/Pills is the largest segment, with a share over 81%. And in terms of End User, the largest End User is Adults, followed by Men, etc.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immune Health Product market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immune Health Product market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immune Health Product market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immune Health Product market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Immune Health Product market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Immune Health Product Breakdown Data by Form

Capsule/Pills

Powder

Liquid

Immune Health Product Breakdown Data by End Users

Children/Teenagers

Men

Adults

The Elderly

Regional Analysis

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Amway

Suntory

GNC

INFINITUS

Herbalife Nutrition

USANA Health Sciences, Inc.

PERFECT

Nestlé SA

H&H Group

China New Era Group

By-health

Black Mores

Glanbia Plc

Nature's

Real Nutriceutical

1 Report Overview
1.1 Study Scope

1.2 Market Analysis by Form

1.2.1 Global Immune Health Product Market Size Growth Rate by Form: 2017 VS 2021 VS 2028

1.2.2 Capsule/Pills

1.2.3 Powder

1.2.4 Liquid

1.3 Market by End Users

1.3.1 Global Immune Health Product Market Share by End Users: 2017 VS 2021 VS 2028

1.3.2 Children/Teenagers

1.3.3 Men

1.3.4 Adults

1.3.5 The Elderly

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Immune Health Product Market Perspective (2017-2028)

2.2 Immune Health Product Growth Trends by Region

2.2.1 Immune Health Product Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Immune Health Product Historic Market Size by Region (2017-2022)

2.2.3 Immune Health Product Forecasted Market Size by Region (2023-2028)

2.3 Immune Health Product Market Dynamics

2.3.1 Immune Health Product Industry Trends

2.3.2 Immune Health Product Market Drivers

2.3.3 Immune Health Product Market Challenges

2.3.4 Immune Health Product Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immune Health Product Players by Revenue

3.1.1 Global Top Immune Health Product Players by Revenue (2017-2022)

3.1.2 Global Immune Health Product Revenue Market Share by Players (2017-2022)

3.2 Global Immune Health Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Immune Health Product Revenue

3.4 Global Immune Health Product Market Concentration Ratio

3.4.1 Global Immune Health Product Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immune Health Product Revenue in 2021

3.5 Immune Health Product Key Players Head office and Area Served

3.6 Key Players Immune Health Product Product Solution and Service

3.7 Date of Enter into Immune Health Product Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Immune Health Product Breakdown Data by Form

4.1 Global Immune Health Product Historic Market Size by Form (2017-2022)

4.2 Global Immune Health Product Forecasted Market Size by Form (2023-2028)

5 Immune Health Product Breakdown Data by End Users

5.1 Global Immune Health Product Historic Market Size by End Users (2017-2022)

5.2 Global Immune Health Product Forecasted Market Size by End Users (2023-2028)

6 North America

6.1 North America Immune Health Product Market Size (2017-2028)

6.2 North America Immune Health Product Market Size by Country (2017-2022)

6.3 North America Immune Health Product Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7 Europe

7.1 Europe Immune Health Product Market Size (2017-2028)

7.2 Europe Immune Health Product Market Size by Country (2017-2022)

7.3 Europe Immune Health Product Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Immune Health Product Market Size (2017-2028)

8.2 Asia-Pacific Immune Health Product Market Size by Country (2017-2022)

8.3 Asia-Pacific Immune Health Product Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9 Latin America

9.1 Latin America Immune Health Product Market Size (2017-2028)

9.2 Latin America Immune Health Product Market Size by Country (2017-2022)

9.3 Latin America Immune Health Product Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immune Health Product Market Size (2017-2028)

10.2 Middle East & Africa Immune Health Product Market Size by Country (2017-2022)

10.3 Middle East & Africa Immune Health Product Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11 Key Players Profiles

11.1 Amway

11.1.1 Amway Company Detail

11.1.2 Amway Business Overview

11.1.3 Amway Immune Health Product Introduction

11.1.4 Amway Revenue in Immune Health Product Business (2017-2022)

11.1.5 Amway Recent Development

11.2 Suntory

11.2.1 Suntory Company Detail

11.2.2 Suntory Business Overview

11.2.3 Suntory Immune Health Product Introduction

11.2.4 Suntory Revenue in Immune Health Product Business (2017-2022)

11.2.5 Suntory Recent Development

11.3 GNC

11.3.1 GNC Company Detail

11.3.2 GNC Business Overview

11.3.3 GNC Immune Health Product Introduction

11.3.4 GNC Revenue in Immune Health Product Business (2017-2022)

11.3.5 GNC Recent Development

11.4 INFINITUS

11.4.1 INFINITUS Company Detail

11.4.2 INFINITUS Business Overview

11.4.3 INFINITUS Immune Health Product Introduction

11.4.4 INFINITUS Revenue in Immune Health Product Business (2017-2022)

11.4.5 INFINITUS Recent Development

11.5 Herbalife Nutrition

11.5.1 Herbalife Nutrition Company Detail

11.5.2 Herbalife Nutrition Business Overview

11.5.3 Herbalife Nutrition Immune Health Product Introduction

11.5.4 Herbalife Nutrition Revenue in Immune Health Product Business (2017-2022)

11.5.5 Herbalife Nutrition Recent Development

11.6 USANA Health Sciences, Inc.

11.6.1 USANA Health Sciences, Inc. Company Detail

11.6.2 USANA Health Sciences, Inc. Business Overview

11.6.3 USANA Health Sciences, Inc. Immune Health Product Introduction

11.6.4 USANA Health Sciences, Inc. Revenue in Immune Health Product Business (2017-2022)

11.6.5 USANA Health Sciences, Inc. Recent Development

11.7 PERFECT

11.7.1 PERFECT Company Detail

11.7.2 PERFECT Business Overview

11.7.3 PERFECT Immune Health Product Introduction

11.7.4 PERFECT Revenue in Immune Health Product Business (2017-2022)

11.7.5 PERFECT Recent Development

11.8 Nestlé SA

11.8.1 Nestlé SA Company Detail

11.8.2 Nestlé SA Business Overview

11.8.3 Nestlé SA Immune Health Product Introduction

11.8.4 Nestlé SA Revenue in Immune Health Product Business (2017-2022)

11.8.5 Nestlé SA Recent Development

11.9 H&H Group

11.9.1 H&H Group Company Detail

11.9.2 H&H Group Business Overview

11.9.3 H&H Group Immune Health Product Introduction

11.9.4 H&H Group Revenue in Immune Health Product Business (2017-2022)

11.9.5 H&H Group Recent Development

11.10 China New Era Group

11.10.1 China New Era Group Company Detail

11.10.2 China New Era Group Business Overview

11.10.3 China New Era Group Immune Health Product Introduction

11.10.4 China New Era Group Revenue in Immune Health Product Business (2017-2022)

11.10.5 China New Era Group Recent Development

11.11 By-health

11.11.1 By-health Company Detail

11.11.2 By-health Business Overview

11.11.3 By-health Immune Health Product Introduction

11.11.4 By-health Revenue in Immune Health Product Business (2017-2022)

11.11.5 By-health Recent Development

11.12 Black Mores

11.12.1 Black Mores Company Detail

11.12.2 Black Mores Business Overview

11.12.3 Black Mores Immune Health Product Introduction

11.12.4 Black Mores Revenue in Immune Health Product Business (2017-2022)

11.12.5 Black Mores Recent Development

11.13 Glanbia Plc

11.13.1 Glanbia Plc Company Detail

11.13.2 Glanbia Plc Business Overview

11.13.3 Glanbia Plc Immune Health Product Introduction

11.13.4 Glanbia Plc Revenue in Immune Health Product Business (2017-2022)

11.13.5 Glanbia Plc Recent Development

11.14 Nature's

11.14.1 Nature's Company Detail

11.14.2 Nature's Business Overview

11.14.3 Nature's Immune Health Product Introduction

11.14.4 Nature's Revenue in Immune Health Product Business (2017-2022)

11.14.5 Nature's Recent Development

11.15 Real Nutriceutical

11.15.1 Real Nutriceutical Company Detail

11.15.2 Real Nutriceutical Business Overview

11.15.3 Real Nutriceutical Immune Health Product Introduction

11.15.4 Real Nutriceutical Revenue in Immune Health Product Business (2017-2022)

11.15.5 Real Nutriceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details